E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA

The Evidence Based Rheumatology Podcast by Michael Putman

Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting to...View more